Neuron BioLabs, S.L. agreed to acquire diagnostics operations, R&D services and patents of Alzheimer's disease from Neuron Bio, SA (BME:NEU) for €9 million on November 11, 2016. All the employees of Neuron Bio except of administration department will move to Neuron BioLabs, S.L. The transaction has been approved by the Board of Neuron Bio, SA. The transaction is expected to close on January 1, 2017. Neuron BioLabs, S.L. cancelled the acquisition of diagnostics operations, R&D services and patents of Alzheimer's disease from Neuron Bio, SA (BME:NEU) on November 11, 2017.